Fundz

Assertio completes merger with Zydus Lifesciences

PUBLIC · TLRYJun 17, 2026

Acquiring Company

Tilray Medical

Acquired Company

Zydus Lifesciences

SeattleOtherInformation TechnologyBiotechnologyAgriculture and FarmingSoftwareHealth CareEducationMedicalAnalyticsCannabisHealth CareMedical

Description

Assertio has announced the completion of its merger with Zydus Lifesciences. This strategic move marks a significant transition for Assertio in enhancing its market presence. The merger also involves changes related to Assertio's convertible senior notes. Both companies are committed to creating value in the healthcare sector.

Company Information

Company

Tilray Medical

Location

E El Segundo Blvd

Seattle, Washington, United States

About

Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. The company aims to elevate lives through moments of connection, offering a house of brands and innovative products. Tilray operates in Canada, the United States, Europe, Australia, and Latin America, supporting over 40 brands across more than 20 countries.

Fundz sees it the moment Tilray Medical makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chris
Likely contact at this company
••••••••@••••••••

See Chris's verified email →

Adam
Senior decision-maker at this company
••••••••@••••••••

See Adam's verified email →

Frank
Senior decision-maker at this company
••••••••@••••••••

See Frank's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Tilray Medical's next move

Learn about Strategic plan

Frequently asked

Who acquired Zydus Lifesciences?

Zydus Lifesciences was acquired by Tilray Medical, based in Seattle. The deal was reported on June 17, 2026. Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with a focus on cannabis, beverage, wellness, and entertainment. Tilray Medical is publicly traded (TLRY) and operates in Other.

When did Tilray Medical acquire Zydus Lifesciences?

Tilray Medical's acquisition of Zydus Lifesciences was reported on June 17, 2026. Assertio has announced the completion of its merger with Zydus Lifesciences. This strategic move marks a significant transition for Assertio in enhancing its market presence. The merger also involves changes related to Assertio's convertible senior notes. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Zydus Lifesciences do?

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. It is privately held, operating in Health Care.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.